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 Abstract 
Depression is implicated as a risk factor for the recurrence of inflammatory bowel 
disease (IBD). Near-infrared spectroscopy (NIRS) and brain-derived neurotrophic factor 
(BDNF) are useful tools for evaluation of brain activity and a depressive state, 
respectively. The aim of this study was to clarify the association between brain activity 
or depressive symptoms and IBD using NIRS and BDNF. This study included 36 
ulcerative colitis (UC) patients, 32 Crohn’s disease (CD) patients, and 17 healthy 
controls (HC). Center for Epidemiologic Studies Depression Scale (CES-D) scores were 
determined, NIRS was performed, and serum BDNF levels were measured in all 
subjects. NIRS showed that the mean oxygenated hemoglobin concentration was 
significantly lower in the frontal lobe in the UC group than in the HC group (HC 167 ± 
106 vs. UC 83.1 ± 85.3, p < 0.05). No significant difference was seen between the HC 
and CD groups. There were also no significant differences in CES-D scores and BDNF 
levels among the groups. Changes in the NIRS values of the UC group may indicate 
decreased brain activity and a fundamental difference between UC and CD, which are 
often lumped together as two types of IBD. 
 
 
 
 
 
 
 INTRODUCTION 
Ulcerative colitis (UC) and Crohn’s disease (CD) are refractory inflammatory bowel 
diseases (IBD) of uncertain etiology. Psychological factors are thought to be heavily 
involved in the onset, worsening, and recurrence of IBD 1. Porcelli and colleagues 1 
found that life events often precede IBD onset or progression. Several studies have 
shown that anxiety and depression are risk factors for disease exacerbation 2 3 4. 
Moreover, the relationship between psychiatric disorders and the course of IBD has 
been examined in prospective studies 5 6 7. An 18-month prospective study of 60 IBD 
patients who achieved remission reported that patients with depression on the Beck 
Depression Inventory (BDI ≥13) had a significantly shorter time to recurrence than 
those without 8. However, this study did not consider UC and CD separately or evaluate 
depression in the active phase versus remission. 
Several tools are available for diagnosing and evaluating the effects of therapy in 
psychiatric diseases. Positron emission tomography and functional magnetic resonance 
imaging are excellent neurological imaging modalities that have advanced our 
understanding of neurological mechanisms, but the unique imaging environment likely 
causes subjects’ stress and anxiety, making these modalities of limited utility in 
assessing psychiatric diseases9. Near-infrared spectroscopy (NIRS) is a new modality 
for evaluating brain function that has a more suitable imaging environment 10 11. When 
used to evaluate brain activity, near infrared light readily passes through the body but is 
absorbed by hemoglobin. This principle is used to estimate changes in oxygenated 
hemoglobin (oxy-Hb) concentrations in the cerebral cortex. NIRS has many advantages: 
 it is noninvasive and requires only minimal patient restraint; the scanner is compact and 
portable and therefore usable in many locations; and testing is uncomplicated12. 
Brain-derived neurotrophic factor (BDNF) is a useful serum marker for evaluation of 
the pathophysiology of mood disorders, depression, and a range of other psychiatric 
diseases. On autopsy, levels of messenger RNA and protein levels of BDNF were low in 
the hippocampus and prefrontal cortex of patients with depression who committed 
suicide 13. Moreover, serum BDNF levels decrease in patients with active depression or 
increasing psychological stress 14 15 16, and levels recover following treatment with 
antidepressant therapy 17.  
No studies have investigated the association between IBD and brain activity using 
quantitative procedures such as NIRS or serum BDNF levels. Thus, the present study 
aimed to investigate brain activity and depressive symptoms in patients with UC and 
CD using NIRS and BDNF and to clarify the correlations between disease activity and 
brain activity and depressive symptoms. 
 
RESULTS 
 
Clinical background characteristics of patients 
 
The clinical background characteristics of the study patients are shown in Table 1. 
Patients with UC were significantly older than those in the healthy control (HC) group 
(HC 23 (22 to 65 years) vs. UC 46 (24 to 77 years), p < 0.01). The ages of the patients 
 in the CD and HC groups did not differ significantly (HC 23 (22 to 65 years) vs. CD 
23.5 (15 to 52 years), p = 0.34). The sex of the patients in the UC, CD, and HC groups 
did not differ significantly. A total of 35 patients had total UC, and one patient had UC 
proctitis. The mean disease duration was 89.4 months. Of the CD patients, one had the 
ileitis subtype, 29 had the ileocolitis subtype, and two had the colitis subtype. The mean 
disease duration was 69.4 months. Albumin and C-reactive protein (CRP) levels did not 
differ significantly between the UC and CD groups. 
 
Comparison of the Center for Epidemiologic Studies Depression Scale (CES-D) scores 
among the UC, CD, and HC groups 
 
 CES-D scores did not differ significantly among the HC, UC, and CD groups (HC 5 (0 
to 30) vs. UC 9.5 (0 to 40) vs. CD 8.5 (0 to 31), not significantly different (n.s.)). 
Comparison of the HC group to the patients with active UC and remission UC showed 
significantly higher scores in the patients with active UC compared with the HC group 
(HC 5 (0 to 30) vs. active UC 13.5 (2 to 40), p < 0.05). Scores did not differ 
significantly among the HC group, patients with active CD, and patients with remission 
CD (HC 5 (0 to 30) vs. active CD 5 (5 to 16) vs. remission CD 9 (0 to 31), n.s.) (Figure 
1). The ratio of CES-D>15 was 10/36 (28%) in the UC, 7/32 (22%) in the CD, and 
3/17(18%) in the HC groups. No significant difference was seen between the HC group 
and either the UC or the CD group. In this study, the UC group was significantly older 
than the HC group (Table 1). To adjust for the effect of age,  multiple regression 
 analysis was performed by entering CES-D as a dependent variable and the presence or 
absence of UC and age as independent variables (n=53). After adjusting for age, there 
was a significant association between UC and CES-D (Table S1). 
 
NIRS data 
 
As shown in Figure 2, NIRS is measured by attaching 52 channels to the head. The 
channels that measure Right Temporal are CHs 1 to 3, 11 to 14, 22 to 24, 32 to 35, and 
43 to 45 (Figure 2a), Front Temporal are CHs 4 to 7, 15 to 17, 25 to 28, 36 to 38, and 46 
to 49 (Figure 2b), and Left Temporal are CHs 8 to 10, 18 to 21, 29 to 31, 39 to 42, and 
50 to 52 (Figure 2c).  
 Changes in mean oxy-Hb concentrations in the HC (green) and UC (red) groups are 
shown in Figure 3a. The horizontal axis represents time, and the vertical axis represents 
changes in mean oxy-Hb concentrations (m(mol/l)/mm; mMmm). Figure 3b shows a 
topographic map of the differences in mean oxy-Hb concentrations. The red, green, and 
blue colors indicate increases, no change, and decreases of mean oxy-Hb concentrations. 
The channels with significant differences in mean oxy-Hb concentrations between the 
HC and UC groups are shown in Figure 3b. The channels marked with yellow (channels 
4, 8, 14, 15, 17, 18, 25 to 29, 37, 46, 47, 49, and 50) were significantly different (p < 
0.05), and those marked with red (channels 9, 19, 35, 36, 38, 39, 45, and 48) were also 
significantly different (p < 0.01) (Table S2). To adjust for the effect of age,  multiple 
regression analysis was performed  by entering mean oxy-Hb concentration as a 
 dependent variable and the presence or absence of UC and age as independent variables 
(n=53). After adjusting for age, there was an association with borderline significance 
between UC and NIRS (Table S1). 
Changes in mean oxy-Hb concentrations in the HC (green) and CD (blue) groups are 
shown in Figure 4a. A topographic map with significant differences in mean oxy-Hb 
concentrations between the HC and CD groups is shown in Figure 4b. No significant 
difference was noted in any channel (Table S3). 
Changes in mean oxy-Hb concentrations in the HC (green) and active UC (purple) 
groups are shown in Figure 5a. Mean oxy-Hb concentrations were significantly 
decreased in the active UC patients (p < 0.05 in channels 3, 9, 24, 35, 36, 38, 39, 46 and 
47 (yellow) and p < 0.01 in channel 49 (red)) (Table S4). 
Changes in mean oxy-Hb concentrations in the HC (green) and UC in remission (red) 
groups are shown in Figure 5b. Mean oxy-Hb concentrations were significantly 
decreased in the patients with UC in remission (p < 0.05 in channels 8, 9, 14, 15, 18, 23, 
28, 29, 35, 37, 39, 46 to 48, and 50 (yellow) and p < 0.01 in channels 19, 36, 38, and 45 
(red)) (Table S5). 
Changes in mean oxy-Hb concentrations did not differ significantly between the 
patients with active UC and UC in remission. This was also true for the patients with 
CD. 
Integral values of mean oxy-Hb concentrations in the frontal lobe were compared 
among the groups. The mean oxy-Hb concentration was significantly decreased in the 
UC group compared with the HC group (HC 167 ± 106 vs. UC 83.1 ± 85.3, p < 0.05). 
 On the other hand, the mean oxy-Hb concentration did not differ significantly between 
the HC and CD groups (HC 167 ± 106 vs. CD 203 ± 176, p = 0.43.). Moreover, the 
mean oxy-Hb concentration was decreased in the patients with active UC or remission 
UC compared with the HC group (HC 167 ± 106 vs. act UC 58.7 ± 63.5 vs. rem UC 
87.9 ± 89.2, p < 0.05). The mean oxy-Hb concentration in the HC group did not differ 
significantly from that in the patients with active CD or remission CD (HC 167 ± 106 vs. 
act CD 198 ± 220 vs. rem CD 204 ± 172, n.s.). 
The above data show that the mean oxy-Hb concentration was decreased in patients 
with UC irrespective of disease activity. The data suggest that the mean oxy-Hb 
concentration was likewise unaffected by disease activity in patients with CD, since the 
mean oxy-Hb concentrations in the patients with active CD and remission CD did not 
differ from those in the HC group. 
 
BDNF data 
 
BDNF levels in the HC, UC, and CD groups were not significantly different (HC 
4.71 (3.26 to 6.08) vs. UC 5.18 (2.94 to 6.29) vs. CD 4.98 (3.65 to 6.34) ng/mL, n.s.). 
Levels likewise did not differ significantly among the HC group, patients with active 
UC, and remission UC (HC 4.71 (3.26 to 6.08) vs. active UC 4.79 (4.01 to 5.48) vs. 
remission UC 5.21 (2.51 to 6.29) ng/mL, n.s.) or among the HC group, patients with 
active CD, and patients with remission CD (HC 4.71 (3.26 to 6.08) vs. active CD 5.16 
(3.65 to 6.26) vs. remission CD 4.94 (3.82 to 6.75) ng/mL, n.s.). 
  
DISCUSSION 
 
 This study evaluated brain activity and depressive symptoms in patients with IBD 
using NIRS and BDNF for the first time. NIRS showed that the mean oxy-Hb 
concentration was significantly decreased in the UC group compared with the HC group 
regardless of UC disease activity. On the other hand, the mean oxy-Hb concentration 
did not differ significantly between the HC and CD groups. In addition, there were no 
significant differences in the CES-D scores and BDNF levels among the HC, UC, and 
CD groups. 
 The relationship between psychiatric factors and IBD has long been a subject of debate 
and remain to be clearly demonstrated. The difficulty in establishing this relationship is 
due in part to the wide-ranging effects of psychiatric factors, the sheer number of factors 
and difficulty testing for them, and the lack of quantitative tests; thus, comparison is 
difficult. Many reports have shown a relationship between IBD and depression using the 
self-rating scale. Brain activity and depressive symptoms in patients with IBD were 
evaluated using CES-D, NIRS, and BDNF levels. The CES-D is a commonly used, 
self-reported depression scale. BDNF levels have been proposed to quantitatively 
measure depression. NIRS using near infrared light is a method to estimate and evaluate 
blood volume changes of the cerebral cortex using the characteristic that near infrared 
light passes easily through a living body but is easily absorbed by the hemoglobin that 
is present. NIRS is covered by National Health Insurance in Japan and helps distinguish 
 between healthy persons, schizophrenia, bipolar disorder, and depression. The 
frontotemporal NIRS signal has been proposed as a supportive tool for assisting with 
the diagnosis of major psychiatric disorders with depressive symptoms, in addition to 
evaluation of brain activity10,11. A decrease in the oxy-Hb concentration with NIRS 
reflects a decrease in frontal lobe function in patients with depression or a depressed 
state 18,19. We recently reported reduced frontal activation in chronic hepatitis C patients 
receiving interferon-based therapy 20 and in female patients with non-alcoholic fatty 
liver disease using NIRS 21. 
 With NIRS, mean oxy-Hb concentrations were lower in the UC group than in the HC 
group in many of the 52 channels. The decrease in the mean oxy-Hb concentration in 
the frontal lobe was similar to the results seen in patients with depression 18,19. However, 
patients with UC were not evaluated for depression using both CES-D and BDNF levels. 
Some studies recently reported that depression may be associated with cognitive 
impairments22,23, and early-onset depression may be related to deficits in attention, 
memory, and executive functioning24,25. Another previous study showed a correlation 
between inflammation and depression 26. Prospective observational studies have shown 
that high blood CRP levels increase the risk of depression 27. These facts may imply that 
the decreased NIRS signal in UC patients was the result of inflammation. However, 
NIRS signals were decreased in UC patients with both active disease and remission. 
Therefore, NIRS in patients with UC may reflect a decrease in overall brain activity. 
 Some studies have shown a correlation between CD and depression28,29. However, all 
results for CES-D, BDNF levels, and NIRS values in patients with CD were equivalent 
 to those in the HC group in the present study. Although UC and CD are often lumped 
together as two types of IBD, the differences between the two conditions in the present 
study may be indicative of a fundamental difference between UC and CD. 
 There are several limitations to this study. First, the UC group was significantly older 
than the HC group (Table 1). To examine the effects of age, multiple regression analysis 
was performed with mean oxy-Hb concentration as a dependent variable and the 
presence or absence of UC and age as independent variables (n=53). Even after 
adjusting for age, there was a borderline significant relationship between UC and NIRS 
(Table S1). Second, the reproducibility of NIRS and intra-individual variance are issues. 
There is a possibility that the oxy-Hb concentration changes decrease with sleepiness 
and anxiety when NIRS measurements are reported30. Therefore, in this study, efforts 
were made to increase the reproducibility of NIRS data by matching the conditions to 
the extent possible, such as performing NIRS in the morning. Furthermore, to 
investigate intra-individual variance in an additional study, 10 mentally healthy subjects 
were measured at intervals of 12 weeks, and the reliability of the NIRS test-retest was 
assessed. The Intraclass Correlation Coefficient (ICC) of the mean oxy-Hb 
concentration during the task segment was calculated for the 52 channels. The 
single-measure ICC was 0.5309, and the average measure ICC was 0.6936, which are 
both reliable, as described by Kakimoto et al31. Finally, it was not possible to examine 
the results of the active stage and the remission stage in the same patient. There were 
few cases, 5 UC cases and 3 CD cases, that were assessed in both the active stage and 
the remission stage, but there were no clear trends in CES-D, NIRS, and BDNF in the 
 cases assessed. A longitudinal study including changes in the active stage and remission 
stage would be very interesting and could be evaluated by increasing the number of 
patients in the future. 
 
MATERIALS AND METHODS 
 
Study group 
 
The study group included 68 patients who visited the Department of 
Gastroenterology of the School of Medicine, Fukushima Medical University on an 
outpatient basis from October 2015 to October 2016 and consented to participate in this 
study and 17 volunteers, for a total of 85 participants. The study was approved by the 
ethics committee of Fukushima Medical University (#2495) and was conducted in 
compliance with the Declaration of Helsinki. All subjects provided their written, 
informed consent to participate in the study. Of the 36 patients with UC, six had disease 
in the active phase, and 30 were in remission. Partial Mayo scores 32 were used to 
evaluate disease activity. Remission was defined as a Mayo score of no greater than 2 
points and no individual sub-score exceeding 1 point. Of the 32 patients with CD, five 
had disease in the active phase, and 27 were in remission. The Crohn’s Disease Activity 
Index (CDAI) 33 was used to evaluate disease activity. A CDAI score of less than 150 
constituted remission. Patients receiving treatment for schizophrenia, depression, or 
bipolar disorder were excluded.  
 The CES-D 34 was used to evaluate depression in each group. Age and sex were 
compared as patient demographic characteristics. The disease subtype, disease duration, 
and serum albumin and CRP levels were determined in the patients in the UC and CD 
groups. All patients underwent NIRS and measurements of BDNF. Serum albumin, CRP, 
NIRS, and BDNF were analyzed on the same day.  
 
NIRS measurements 
 
NIRS measurements have been discussed previously 11. In this study, oxy-Hb, 
deoxy-Hb, and total Hb were measured with a 52-channel NIRS machine (Hitachi 
ETG400 Hitachi Medical Corp., Tokyo, Japan) using two wavelengths of near-infrared 
light (695 and 830 nm). A verbal fluency task (VFT) was used as an activating task 
during NIRS analysis. The 52-channel device was connected symmetrically around the 
prefrontal cortex 35 (Figure 2). The lower and forward-most channels were placed along 
the line connecting T3-Fpz-T4, based on the international 10-20 system. Compliance 
with the scalp measurement sites of the international 10-20 system allows prediction of 
the measurement sites on the brain surface with relatively high accuracy 35,36. NIRS 
signal changes were measured during a 10-s pre-task baseline period, a 60-s activation 
period, and a 55-s post-task baseline period (Figure 6). The rate of oxy-Hb 
concentration data sampling was 0.1 s. The obtained data were analyzed using the 
“integral mode”: the pre-task baseline was set as the mean over a 10-s period 
just before the task period, and the post-task baseline was fixed as the mean 
 over a 5-s period, 50 s after the task period. Linear fitting between the pre 
and post-task baselines was applied to data between the two baselines. The 
average oxy-Hb concentration during the VFT that was performed for 60 seconds was 
used for the analysis. The algorithm developed by Takizawa et al11 was used to 
automatically reject data with artifacts. Data are expressed as waveforms and 
topographic maps. 
 
Activation task 
 
The VFT is widely used to test frontal lobe function 9 and is commonly used with 
NIRS analysis. Changes in hemoglobin oxygenation occur in people performing the 
VFT. Artifacts must be eliminated by having the subject sit in a chair, relax, and move 
as little as possible during the test. The subject is first prompted by a voice saying, 
“Start /a/, /i/, /u/, /e/, /o/” to repeat the utterance “/a/, /i/, /u/, /e/, /o/” for 30 s. The 
baseline activity recorded during this meaningless utterance is used to remove the effect 
of vocalization on brain activity from the data. The subject is next prompted by voice to 
vocalize as many words as possible that start with a certain letter. This is done in three 
20-s sets. The subjects are verbally prompted to vocalize words starting with a certain 
letter to increase the difficulty of the task. The exercise is scored by recording the 
number of words uttered every 20 s. Finally, the subject is prompted by a voice saying, 
“Stop /a/, /i/, /u/, /e/, /o/” to stop the task and repeat “/a/, /i/, /u/, /e/, /o/” for 70 s. 
 
 Questionnaire 
 
All participants were assessed with the CES-D before undergoing NIRS analysis. 
Widely used to help inform the diagnosis of depression, the CES-D is a 
self-administered instrument 34 with the following assessment criteria: <15, no 
depression; 15−21, mild to moderate depression; and >21, possibility of major 
depression. A positive score of 16 or more indicates the possibility of depression. 
 
BDNF assay 
 
Serum BDNF levels were determined with the BDNF Emax ImmunoAssay Kit 
(Promega, Madison, WI). A carbonate buffer (pH 9.7) was prepared on the day before 
analysis and used to dilute the anti-BDNF monoclonal antibody reagent by a factor of 
1000. The resulting solution was pipetted into an ELISA plate at 100 μL per well and 
allowed to stand for 18 h at 4°C. The wells were rinsed once with TBS-T, which was 
replaced with blocking buffer, and allowed to stand at room temperature for 1 h. The 
wells were then rinsed once with TBS-T, which was replaced with the samples, and the 
plate was shaken on a shaker for 2 h. The wells were then rinsed five times with TBS-T, 
which was replaced with anti-human BDNF polyclonal antibody reagent. The plate was 
returned to the shaker and shaken for 2 h. The wells were rinsed five times with TBS-T, 
which was replaced with anti-IgY HRP, and the plate was shaken on a shaker for 1 h. 
The wells were rinsed five times with TBS-T, and TMB One Solution was added. The 
 plate was shaken for 10 min until the solution turned blue, and then the reaction was 
stopped with 1 N hydrochloric acid. Absorbance was determined at 450 nm using the 
xMark system (Bio-Rad). The range of the standard curve was 7.8 to 500 pg/mL. 
 
Statistical analysis 
 
 Continuous data are expressed as medians (interquartile range). The three groups (HC 
vs. UC vs. CD) were compared using the Mann-Whitney U test. For the analysis of 
NIRS data, the averages of oxy-Hb, deoxy-Hb, and total-Hb were calculated and 
analyzed using one-way repeated-measures ANOVA. All statistical analyses were 
carried out using SPSS 24.0 J software (IBM Inc., Armonk, NY, USA) and MATLAB 
R2011 (MathWorks Inc., Natick, MA). A p value <0.05 was considered significant. 
 
Conclusions 
The quantitative data produced from the NIRS and BDNF tests in this study allow 
comparisons among patients with different disease variants and activity levels. We hope 
that the present study helps further efforts to establish a clear correlation between IBD 
and psychiatric factors. 
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 Figure legends 
 
Figure 1. Comparisons of CES-D scores among the HC, UC, and CD groups; HC, 
active UC, and UC in remission groups; and HC, active CD, and CD in remission 
groups. 
Figure a. Scores in the UC and CD groups do not differ significantly from HC group 
scores. 
Figure b. Scores in the active UC group are significantly higher compared with the HC 
group. 
Figure c. Scores in the active CD and remission CD groups do not differ significantly 
from HC group scores. 
 
Figure 2. Measurement points of 52 channels for near-infrared spectroscopy.  
The measuring positions of the device are superimposed on the 3D-reconstructed 
cerebral surface, based on magnetic resonance imaging, in the right temporal (a), frontal 
(b), and left temporal (c) brain regions. The 52 measuring positions are labeled channel 
(ch) 1 to 52, from the right posterior to the left posterior. 
 
Figure 3. 
Figure a. Comparison of changes in mean oxy-Hb concentration in the HC (green) and 
UC (red) groups. 
Figure b. Topographic map of the differences in mean oxy-Hb concentration changes 
 between the UC and HC groups. 
THE mean oxy-Hb concentration is significantly decreased in the UC group (p < 0.05 in 
channels 4, 8, 14, 15, 17, 18, 25 to 29, 37, 46, 47, 49, and 50 (yellow) and p < 0.01 in 
channels 9, 19, 35, 36, 38, 39, 45, and 48 (red)). 
 
Figure 4. 
Figure a. Comparison of changes in mean oxy-Hb concentrations in the HC (green) and 
CD (blue) groups. 
Figure b. Topographic map of the differences in mean oxy-Hb concentration changes 
between the CD and HC groups. 
No significant differences are noted in any channel. 
 
Figure 5. 
Figure a. Comparison of changes in the mean oxy-Hb concentration in the HC (green) 
and active UC (purple) groups. The mean oxy-Hb concentration is significantly 
decreased in the active UC patients (p < 0.05 in channels 3, 9, 24, 35, 36, 38, 39, 46 and 
47 (yellow) and p < 0.01 in channel 49 (red)). 
Figure b. Comparison of changes in the mean oxy-Hb concentration in the HC (green) 
and UC in remission (red) groups. 
The mean oxy-Hb concentration is significantly decreased in the patients with UC in 
remission (p < 0.05 in channels 8, 9, 14, 15, 18, 23, 28, 29, 35, 37, 39, 46 to 48, and 50 
(yellow) and p < 0.01 in channels 19, 36, 38, and 45 (red)).  
 Figure 6. Time-dependent changes in oxy-hemoglobin (oxy-Hb) concentration in an 
NIRS signal waveform (sample). The average waveforms of time-dependent changes in 
mean oxy-Hb concentrations in the channels. (1) 10-s pre-task baseline period (2) 60-s 
activation period (3) in the 55-s post-task baseline period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 1. Characteristics of the UC, CD, and HC groups 
 
Data are means and medians (interquartile range). Statistical analysis was conducted 
using the Mann-Whitney U test. 
* Control vs. UC. **Control vs. CD. ***UC vs. CD 
5-ASA, 5-aminosalicylic acid; AZA, azathioprine;  
Anti-TNF-α agent, anti-tumor necrosis factor-α agent 
Alb, Albumin; CRP, C-reactive protein 
 
 
 
 
 
 
UC 
(n=36) 
CD 
(n=32) 
Control 
(n=17) 
p-value 
 
Age(year) 46(24-77) 23.5(15-52) 23(22-65) <0.01*/0.34** 
Gender(men/women) 19/17 26/6 13/4  0.10*/0.61** 
type total   35 
proctitis 1 
lleitis     1 
lleocolitis 29 
colitis     2 
- - 
Disease duration 
   active stage 
   remission stage 
89.4(1-438) 
50.5(2-168) 
97.2(1-438) 
69.4(1-419) 
31.8(1-95) 
76.3(2-419) 
- - 
Medication 
   No treatment 
   5-ASA 
   5-ASA+AZA 
   5-ASA+antiTNF  
αagent 
  5-ASA+Steroid 
 
     2 
    15 
     4 
     7 
      
         8 
      
     0 
     3 
     0 
     29 
 
          0 
  
Alb(g/dl) 4.2(2.7-5) 4.1(2.5-5) - 0.14*** 
CRP(mg/dl) 0.11(0.03-16) 0.27(0.03-7) - 0.37*** 
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 Table S1. Multiple regression model included CES-D or NIRS as dependent variable 
and the age and UC as independent variables. 
 
 Variable       β p-value 
CES-D 
 
NIRS 
Age, per 1 year 
UC, yes 
Age, per 1 year 
UC, yes 
−0.26 
 0.33 
−0.15 
−0.31 
0.126 
0.049 
0.349 
0.053 
CES-D, Center for Epidemiologic Studies Depression Scale; 
NIRS, Near-infrared spectroscopy; 
β, standardized coefficients beta; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table S2. Mean and standard deviation for each channel of HC and UC 
 
 HC UC p-value 
CH1 
CH2 
CH3 
CH4 
CH5 
CH6 
CH7 
CH8 
CH9 
CH10 
CH11 
CH12 
CH13 
CH14 
CH15 
CH16 
CH17 
CH18 
CH19 
CH20 
CH21 
CH22 
CH23 
CH24 
CH25 
CH26 
CH27 
CH28 
CH29 
0.05 ± 0.15 
0.10 ± 0.18 
0.14 ± 0.13 
0.17 ± 0.16 
0.10 ± 0.17 
0.09 ± 0.12 
0.14 ± 0.12 
0.16 ± 0.13 
0.20 ± 0.13 
0.16 ± 0.16 
0.15 ± 0.19 
0.14 ± 0.22 
0.21 ± 0.17 
0.23 ± 0.19 
0.21 ± 0.25 
0.10 ± 0.18 
0.17 ± 0.16 
0.25 ± 0.17 
0.35 ± 0.21 
0.18 ± 0.20 
0.19 ± 0.07 
0.14 ± 0.17 
0.25 ± 0.15 
0.22 ± 0.11 
0.24 ± 0.19 
0.23 ± 0.19 
0.19 ± 0.19 
0.27 ± 0.22 
0.29 ± 0.16 
0.10 ± 0.14 
0.07 ± 0.16 
0.10 ± 0.16 
0.08 ± 0.11 
0.05 ± 0.07 
0.04 ± 0.10 
0.07 ± 0.13 
0.06 ± 0.14 
0.06 ± 0.14 
0.08 ± 0.12 
0.16 ± 0.15  
0.13 ± 0.13 
0.18 ± 0.19 
0.12 ± 0.15 
0.08 ± 0.11 
0.11 ± 0.12 
0.09 ± 0.12 
0.11 ± 0.18 
0.12 ± 0.18 
0.14 ± 0.12 
0.14 ± 0.14 
0.12 ± 0.16 
0.13 ± 0.17 
0.18 ± 0.19 
0.14 ± 0.14 
0.12 ± 0.14 
0.10 ± 0.12 
0.14 ± 0.15 
0.16 ± 0.19 
 0.290 
 0.433 
 0.407 
 0.040* 
 0.147 
 0.116 
 0.084 
 0.018* 
 0.008* 
 0.070 
 0.856 
 0.830 
 0.649 
 0.029* 
 0.011* 
 0.998 
 0.048* 
 0.011* 
<0.001* 
 0.416 
 0.254 
 0.825 
 0.072 
 0.480 
 0.025* 
 0.027* 
 0.051* 
 0.020* 
 0.014* 
 CH30 
CH31 
CH32 
CH33 
CH34 
CH35 
CH36 
CH37 
CH38 
CH39 
CH40 
CH41 
CH42 
CH43 
CH44 
CH45 
CH46 
CH47 
CH48 
CH49 
CH50 
CH51 
CH52 
0.28 ± 0.26 
0.19 ± 0.10 
0.23 ± 0.19 
0.26 ± 0.29 
0.29 ± 0.27 
0.31 ± 0.18 
0.30 ± 0.20 
0.33 ± 0.20 
0.28 ± 0.21 
0.31 ± 0.14 
0.30 ± 0.21 
0.27 ± 0.23 
0.24 ± 0.18 
0.28 ± 0.25 
0.35 ± 0.35 
0.40 ± 0.22 
0.30 ± 0.17 
0.32 ± 0.16 
0.32 ± 0.19 
0.30 ± 0.16 
0.31 ± 0.18 
0.36 ± 0.29 
0.27 ± 0.26 
0.18 ± 0.15 
0.14 ± 0.15 
0.19 ± 0.16 
0.17 ± 0.20 
0.24 ± 0.20 
0.17 ± 0.15 
0.11 ± 0.16 
0.18 ± 0.17 
0.11 ± 0.15 
0.18 ± 0.17 
0.20 ± 0.17 
0.25 ± 0.19 
0.17 ± 0.20 
0.20 ± 0.17 
0.28 ± 0.17 
0.22 ± 0.18 
0.16 ± 0.17 
0.17 ± 0.20 
0.16 ± 0.15 
0.17 ± 0.17 
0.18 ± 0.19 
0.34 ± 0.30 
0.19 ± 0.27 
 0.127 
 0.339 
 0.431 
 0.236 
 0.498 
 0.004* 
<0.001* 
 0.012* 
 0.002* 
<0.001* 
 0.083 
 0.781 
 0.224 
 0.255 
 0.423 
 0.007* 
 0.012* 
 0.015* 
 0.007* 
 0.016* 
 0.031* 
 0.905 
 0.404 
All data are expressed as the mean ± standard deviation 
Statistical analysis was conducted using Mann-Whitney U test. 
* Significant differences between UC and HC group (p<0.05). 
 
 
 
 
 
 
 Table S3. Mean and standard deviation for each channel of HC and CD 
 
 HC CD p-value 
CH1 
CH2 
CH3 
CH4 
CH5 
CH6 
CH7 
CH8 
CH9 
CH10 
CH11 
CH12 
CH13 
CH14 
CH15 
CH16 
CH17 
CH18 
CH19 
CH20 
CH21 
CH22 
CH23 
CH24 
CH25 
CH26 
CH27 
CH28 
CH29 
0.05 ± 0.15 
0.10 ± 0.18 
0.14 ± 0.13 
0.17 ± 0.16 
0.10 ± 0.17 
0.09 ± 0.12 
0.14 ± 0.12 
0.16 ± 0.13 
0.20 ± 0.13 
0.16 ± 0.16 
0.15 ± 0.19 
0.14 ± 0.22 
0.21 ± 0.17 
0.23 ± 0.19 
0.21 ± 0.25 
0.10 ± 0.18 
0.17 ± 0.16 
0.25 ± 0.17 
0.35 ± 0.21 
0.18 ± 0.20 
0.19 ± 0.07 
0.14 ± 0.17 
0.25 ± 0.15 
0.22 ± 0.11 
0.24 ± 0.19 
0.23 ± 0.19 
0.19 ± 0.19 
0.27 ± 0.22 
0.29 ± 0.16 
0.16 ± 0.18 
0.13 ± 0.21 
0.25 ± 0.20 
0.17 ± 0.16 
0.11 ± 0.13 
0.11 ± 0.11 
0.16 ± 0.13 
0.20 ± 0.24 
0.17 ± 0.15 
0.11 ± 0.18 
0.17 ± 0.20  
0.16 ± 0.22 
0.20 ± 0.24 
0.28 ± 0.25 
0.22 ± 0.24 
0.22 ± 0.22 
0.20 ± 0.19 
0.29 ± 0.27 
0.26 ± 0.17 
0.15 ± 0.15 
0.20 ± 0.16 
0.15 ± 0.23 
0.16 ± 0.39 
0.26 ± 0.25 
0.31 ± 0.32 
0.30 ± 0.30 
0.30 ± 0.26 
0.31 ± 0.25 
0.30 ± 0.20 
 0.057 
 0.772 
 0.074 
 0.950 
 0.773 
 0.608 
 0.497 
 0.510 
 0.611 
 0.419 
 0.864 
 0.787 
 0.942 
 0.486 
 0.961 
 0.090 
 0.705 
 0.566 
 0.148 
 0.597 
 0.724 
 0.891 
 0.484 
 0.475 
 0.380 
 0.413 
 0.114 
 0.592 
 0.898 
 CH30 
CH31 
CH32 
CH33 
CH34 
CH35 
CH36 
CH37 
CH38 
CH39 
CH40 
CH41 
CH42 
CH43 
CH44 
CH45 
CH46 
CH47 
CH48 
CH49 
CH50 
CH51 
CH52 
0.28 ± 0.26 
0.19 ± 0.10 
0.23 ± 0.19 
0.26 ± 0.29 
0.29 ± 0.27 
0.31 ± 0.18 
0.30 ± 0.20 
0.33 ± 0.20 
0.28 ± 0.21 
0.31 ± 0.14 
0.30 ± 0.21 
0.27 ± 0.23 
0.24 ± 0.18 
0.28 ± 0.25 
0.35 ± 0.35 
0.40 ± 0.22 
0.30 ± 0.17 
0.32 ± 0.16 
0.32 ± 0.19 
0.30 ± 0.16 
0.31 ± 0.18 
0.36 ± 0.29 
0.27 ± 0.26 
0.19 ± 0.24 
0.12 ± 0.17 
0.17 ± 0.24 
0.23 ± 0.32 
0.21 ± 0.37 
0.35 ± 0.34 
0.35 ± 0.33 
0.41 ± 0.46 
0.29 ± 0.27 
0.34 ± 0.27 
0.31 ± 0.25 
0.30 ± 0.34 
0.18 ± 0.20 
0.32 ± 0.36 
0.34 ± 0.33 
0.25 ± 0.28 
0.35 ± 0.31 
0.41 ± 0.41 
0.38 ± 0.34 
0.32 ± 0.28 
0.28 ± 0.29 
0.34 ± 0.37 
0.30 ± 0.33 
 0.327 
 0.255 
 0.412 
 0.805 
 0.513 
 0.670 
 0.537 
 0.604 
 0.864 
 0.693 
 0.990 
 0.774 
 0.327 
 0.696 
 0.903 
 0.093 
 0.520 
 0.460 
 0.567 
 0.808 
 0.731 
 0.891 
 0.741 
All data are expressed as the mean ± standard deviation 
Statistical analysis was conducted using Mann-Whitney U test. 
 
 
 
 
 
 
 
 Table S4. Mean and standard deviation for each channel of HC and Active UC 
 
 HC Active UC p-value 
CH1 
CH2 
CH3 
CH4 
CH5 
CH6 
CH7 
CH8 
CH9 
CH10 
CH11 
CH12 
CH13 
CH14 
CH15 
CH16 
CH17 
CH18 
CH19 
CH20 
CH21 
CH22 
CH23 
CH24 
CH25 
CH26 
CH27 
CH28 
CH29 
0.05 ± 0.15 
0.10 ± 0.18 
0.14 ± 0.13 
0.17 ± 0.16 
0.10 ± 0.17 
0.09 ± 0.12 
0.14 ± 0.12 
0.16 ± 0.13 
0.20 ± 0.13 
0.16 ± 0.16 
0.15 ± 0.19 
0.14 ± 0.22 
0.21 ± 0.17 
0.23 ± 0.19 
0.21 ± 0.25 
0.10 ± 0.18 
0.17 ± 0.16 
0.25 ± 0.17 
0.35 ± 0.21 
0.18 ± 0.20 
0.19 ± 0.07 
0.14 ± 0.17 
0.25 ± 0.15 
0.22 ± 0.11 
0.24 ± 0.19 
0.23 ± 0.19 
0.19 ± 0.19 
0.27 ± 0.22 
0.29 ± 0.16 
0.05 ± 0.10 
0.04 ± 0.18 
0.01 ± 0.12 
0.03 ± 0.04 
0.01 ± 0.04 
0.02 ± 0.04 
0.02 ± 0.08 
0.10 ± 0.14 
0.05 ± 0.08 
0.07 ± 0.06 
0.07 ± 0.10 
0.16 ± 0.08 
0.11 ± 0.08 
0.06 ± 0.04 
0.04 ± 0.08 
0.10 ± 0.09 
0.06 ± 0.06  
0.12 ± 0.15 
0.18 ± 0.27 
0.15 ± 0.07 
0.11 ± 0.13 
0.12 ± 0.17 
0.27 ± 0.15 
0.09 ± 0.10 
0.09 ± 0.10 
0.08 ± 0.09 
0.08 ± 0.10 
0.10 ± 0.14 
0.18 ± 0.23 
 0.985 
 0.526 
 0.034* 
 0.089 
 0.264 
 0.271 
 0.063 
 0.334 
 0.021* 
 0.247 
 0.390 
 0.873 
 0.365 
 0.051 
 0.120 
 0.916 
 0.093 
 0.140 
 0.168 
 0.682 
 0.147 
 0.892 
 0.869 
 0.020* 
 0.069 
 0.091 
 0.205 
 0.105 
 0.236 
 CH30 
CH31 
CH32 
CH33 
CH34 
CH35 
CH36 
CH37 
CH38 
CH39 
CH40 
CH41 
CH42 
CH43 
CH44 
CH45 
CH46 
CH47 
CH48 
CH49 
CH50 
CH51 
CH52 
0.28 ± 0.26 
0.19 ± 0.10 
0.23 ± 0.19 
0.26 ± 0.29 
0.29 ± 0.27 
0.31 ± 0.18 
0.30 ± 0.20 
0.33 ± 0.20 
0.28 ± 0.21 
0.31 ± 0.14 
0.30 ± 0.21 
0.27 ± 0.23 
0.24 ± 0.18 
0.28 ± 0.25 
0.35 ± 0.35 
0.40 ± 0.22 
0.30 ± 0.17 
0.32 ± 0.16 
0.32 ± 0.19 
0.30 ± 0.16 
0.31 ± 0.18 
0.36 ± 0.29 
0.27 ± 0.26 
0.20 ± 0.19 
0.16 ± 0.13 
0.16 ± 0.16 
0.14 ± 0.19 
0.33 ± 0.19 
0.12 ± 0.10 
0.07 ± 0.13 
0.16 ± 0.17 
0.06 ± 0.07 
0.12 ± 0.17 
0.21 ± 0.19 
0.19 ± 0.15 
0.19 ± 0.15 
0.18 ± 0.14 
0.28 ± 0.21 
0.27 ± 0.20 
0.08 ± 0.13 
0.12 ± 0.20 
0.14 ± 0.13 
0.10 ± 0.09 
0.16 ± 0.15 
0.22 ± 0.23 
0.17 ± 0.18 
 0.554 
 0.592 
 0.432 
 0.368 
 0.795 
 0.022* 
 0.032* 
 0.129 
 0.041* 
 0.020* 
 0.374 
 0.549 
 0.602 
 0.392 
 0.715 
 0.372 
 0.012* 
 0.036* 
 0.052 
 0.009* 
 0.108 
 0.343 
 0.403 
All data are expressed as the mean ± standard deviation 
Statistical analysis was conducted using Mann-Whitney U test. 
* Significant differences between Active UC and HC group (p<0.05). 
 
 
 
 
 
 
 Table S5. Mean and standard deviation for each channel of HC and Remission UC 
 
 HC Remission UC p-value 
CH1 
CH2 
CH3 
CH4 
CH5 
CH6 
CH7 
CH8 
CH9 
CH10 
CH11 
CH12 
CH13 
CH14 
CH15 
CH16 
CH17 
CH18 
CH19 
CH20 
CH21 
CH22 
CH23 
CH24 
CH25 
CH26 
CH27 
CH28 
CH29 
0.05 ± 0.15 
0.10 ± 0.18 
0.14 ± 0.13 
0.17 ± 0.16 
0.10 ± 0.17 
0.09 ± 0.12 
0.14 ± 0.12 
0.16 ± 0.13 
0.20 ± 0.13 
0.16 ± 0.16 
0.15 ± 0.19 
0.14 ± 0.22 
0.21 ± 0.17 
0.23 ± 0.19 
0.21 ± 0.25 
0.10 ± 0.18 
0.17 ± 0.16 
0.25 ± 0.17 
0.35 ± 0.21 
0.18 ± 0.20 
0.19 ± 0.07 
0.14 ± 0.17 
0.25 ± 0.15 
0.22 ± 0.11 
0.24 ± 0.19 
0.23 ± 0.19 
0.19 ± 0.19 
0.27 ± 0.22 
0.29 ± 0.16 
0.11 ± 0.14 
0.07 ± 0.16 
0.12 ± 0.16 
0.09 ± 0.12 
0.06 ± 0.08 
0.04 ± 0.11 
0.08 ± 0.14 
0.05 ± 0.14 
0.06 ± 0.15 
0.08 ± 0.13 
0.19 ± 0.16  
0.12 ± 0.14 
0.19 ± 0.20 
0.13 ± 0.16 
0.09 ± 0.11 
0.10 ± 0.12 
0.10 ± 0.13 
0.11 ± 0.19 
0.11 ± 0.16 
0.14 ± 0.13 
0.14 ± 0.15 
0.12 ± 0.16 
0.11 ± 0.18 
0.20 ± 0.20 
0.15 ± 0.14 
0.12 ± 0.15 
0.11 ± 0.13 
0.15 ± 0.15 
0.15 ± 0.18 
 0.230 
 0.491 
 0.683 
 0.089 
 0.245 
 0.160 
 0.152 
 0.014* 
 0.017* 
 0.099 
 0.605 
 0.772 
 0.755 
 0.068 
 0.027* 
 0.975 
 0.098 
 0.015* 
<0.001* 
 0.450 
 0.316 
 0.832 
 0.038* 
 0.748 
 0.058 
 0.053 
 0.087 
 0.041* 
 0.012* 
 CH30 
CH31 
CH32 
CH33 
CH34 
CH35 
CH36 
CH37 
CH38 
CH39 
CH40 
CH41 
CH42 
CH43 
CH44 
CH45 
CH46 
CH47 
CH48 
CH49 
CH50 
CH51 
CH52 
0.28 ± 0.26 
0.19 ± 0.10 
0.23 ± 0.19 
0.26 ± 0.29 
0.29 ± 0.27 
0.31 ± 0.18 
0.30 ± 0.20 
0.33 ± 0.20 
0.28 ± 0.21 
0.31 ± 0.14 
0.30 ± 0.21 
0.27 ± 0.23 
0.24 ± 0.18 
0.28 ± 0.25 
0.35 ± 0.35 
0.40 ± 0.22 
0.30 ± 0.17 
0.32 ± 0.16 
0.32 ± 0.19 
0.30 ± 0.16 
0.31 ± 0.18 
0.36 ± 0.29 
0.27 ± 0.26 
0.17 ± 0.15 
0.14 ± 0.16 
0.20 ± 0.16 
0.17 ± 0.22 
0.22 ± 0.21 
0.17 ± 0.16 
0.12 ± 0.16 
0.18 ± 0.17 
0.12 ± 0.16 
0.19 ± 0.17 
0.20 ± 0.17 
0.26 ± 0.20 
0.16 ± 0.21 
0.21 ± 0.18 
0.28 ± 0.17 
0.21 ± 0.18 
0.18 ± 0.18 
0.18 ± 0.20 
0.17 ± 0.15 
0.19 ± 0.18 
0.19 ± 0.20 
0.40 ± 0.33 
0.20 ± 0.30 
 0.127 
 0.337 
 0.522 
 0.327 
 0.422 
 0.013* 
 0.002* 
 0.020* 
 0.007* 
 0.019* 
 0.092 
 0.898 
 0.227 
 0.339 
 0.452 
 0.007* 
 0.036* 
 0.028* 
 0.016* 
 0.050 
 0.048* 
 0.757 
 0.500 
All data are expressed as the mean ± standard deviation 
Statistical analysis was conducted using Mann-Whitney U test. 
* Significant differences between Remission UC 
